Leptomeningeal disease: current diagnostic and therapeutic strategies.

about

Intra-operative cerebrospinal fluid sampling versus post-operative lumbar puncture for detection of leptomeningeal disease in malignant paediatric brain tumours.

P2860

Q55271540-D650A0B7-467A-4368-8E93-AA600BA39451

P2860

Leptomeningeal disease: current diagnostic and therapeutic strategies.

Item

http://www.wikidata.org/entity/Q42700664

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@en

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@nl

type

Item

label

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@en

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@nl

prefLabel

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@en

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@nl

P1476

Leptomeningeal disease: current diagnostic and therapeutic strategies.

@en

P2093

Aladine A Elsamadicy

http://www.w3.org/2001/XMLSchema#string

Gautam Nayar

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Clarke

http://www.w3.org/2001/XMLSchema#string

Kimberly L Blackwell

http://www.w3.org/2001/XMLSchema#string

Pakawat Chongsathidkiet

http://www.w3.org/2001/XMLSchema#string

Peter E Fecci

http://www.w3.org/2001/XMLSchema#string

Shivanand P Lad

http://www.w3.org/2001/XMLSchema#string

Tiffany Ejikeme

http://www.w3.org/2001/XMLSchema#string

P2860

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions

Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

P304

73312-73328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20272

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29069871

http://www.w3.org/2001/XMLSchema#string

P932

5641214

http://www.w3.org/2001/XMLSchema#string

Leptomeningeal disease: current diagnostic and therapeutic strategies.

about

P2860

P2860

Leptomeningeal disease: current diagnostic and therapeutic strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932